Inaugural Redefining Early Stage Investments

Asia Week – Shanghai & Taipei, Nov. 12-14, 2019

The Asia region has become more central to life science innovation and investment over the last several years, and at LSN we have aimed to welcome investors and other core strategic partners from Asia to join us at RESI and be part of our global ecosystem. For the first time, RESI will be heading to Asia in November, with two events in one week – RESI Shanghai on November 12th, and RESI Taipei on November 14th.

These two events will provide LSN’s global tribe of early-stage entrepreneurs and investors with a venue to meet face to face with partners from China, Taiwan, and other key Pacific Rim life science hubs. With Asia increasingly providing research & development services, investment funds and talent in life sciences, RESI Asia will be a key opportunity to get involved with life science innovation in the region and start new global partnerships.

You can now register for RESI Taipei and RESI Shanghai. We look forward to you joining us on our global journey.

Grants, Seed, Angel, Series A, Series B

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development.  What‘s unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.

LSN invites tech hubs, entrepreneurs, investors, strategic partners, and service providers to the RESI Conference.

YOU ARE INVITED
Incubators, tech transfer offices, universities, hospitals, research labs and their constituents to get on the radar of investors and channel partners. Biotech, Medtech, Diagnostics and Digital Health to source global investors and strategic partners, create relationships, and potentially, secure funding
Tech Hubs & Their Constituents Early Stage Fundraising Companies
Seeking $15K - $2M Seeking $2M - $10M+
Grants - Seed - Angel Series A - Series B
  • 1:1 Ratio of Entrepreneurs to Investors

  • Cutting-edge Technologies across Drugs, Devices, Diagnostics, & Digital Health

  • 10 Type of Early-Stage Investors from North America, Europe, Asia…

  • A Full Day of One-to-One Partnering Meetings and Networking

  • Insightful Investor Panels and Entrepreneur Workshops

  • Global Gathering of Tech Hubs & Their Constituents

Check out the Program Guide of RESI Boston 2019 Conference